PAR · PEUG.PA
Peugeot Invest S.A.
€54.50-€0.20 (-0.37%)
Peugeot Invest S.A.’s quoted price sits in the lower half of its reported 52-week range, 31.01% below the high.
Loading market information…
PAR · LTA.PA · EUR
Stock price, dividends, earnings
Quote as of Oct 30, 2026, 01:30 PM UTC. Cached market data; not a live quote.
One-year closing-price history · EUR. Historical prices are not a forecast.
Altamir SCA’s quoted price sits in the lower half of its reported 52-week range, 25.97% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Altamir SCA’s forward annual dividend is €1.08 per share, paid annual. The forward yield is 4.74% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow Altamir SCA’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Altamir SCA, previously known as Altamir Amboise, is a Paris-based private equity firm established in 1995. The company employs a dual investment strategy, engaging in both direct investments and fund-of-funds, primarily targeting small and mid-cap companies. For its direct investments, Altamir concentrates on the middle market, executing buyout and growth capital transactions, and shows a particular interest in acquiring underdeveloped segments of larger corporate entities. When investing through other funds, the firm prioritizes private equity funds that specialize in growth capital and leveraged buyouts, often seeking a majority or lead shareholder position within these investments. Its sector focus is broad, encompassing healthcare, technology (including TMT and digital enterprises), various services, retail and distribution, consumer goods, and business and financial services. Within healthcare, Altamir specifically seeks out high-growth potential companies across health services (such as hospitalization, home care, and medical analysis), medical devices, niche pharmaceutical laboratories, and related areas like dermo-cosmetics, galenic development, and services/databases for health organizations. Geographically, Altamir targets unlisted companies across Europe, with a keen focus on Belgium, France, Luxembourg, Switzerland, Monaco, Italy, the Netherlands, Germany, and French-speaking European regions. It also extends its reach to North America (United States and Canada) and major emerging economies including China, India, and Brazil. For smaller and mid-sized companies, the firm prefers Continental Europe, particularly France, Italy, and the Benelux countries, while larger companies are sought across Europe, North America, and the aforementioned emerging markets. Investment sizes range from an enterprise value of €50 million to €500 million for small to mid-cap entities, and €500 million to €3,000 million for larger enterprises. Altamir makes balance sheet investments and frequently collaborates with Apax Partners France and Amboise Investissement, investing and divesting alongside them under identical terms. Furthermore, it directly invests in funds managed or advised by Apax Partners France and Apax Partners LLC. The firm typically aims for an investment horizon of five years before exiting.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 02:33 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
Latest available per-share figures in EUR. The payout ratio compares dividends with earnings.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
€54.50-€0.20 (-0.37%)
Peugeot Invest S.A.’s quoted price sits in the lower half of its reported 52-week range, 31.01% below the high.
€7.53-€0.02 (-0.26%)
Antin Infrastructure Partners S.A.’s quoted price sits in the lower half of its reported 52-week range, 35.31% below the high.
€17.24-€0.20 (-1.15%)
VIEL & Cie, S.A.’s quoted price sits in the upper half of its reported 52-week range, 13.37% below the high.
€85.60-€0.49 (-0.57%)
Caisse Régionale de Crédit Agricole Mutuel de Paris et d'Ile-de-France’s quoted price sits in the lower half of its reported 52-week range, 34.76% below the high.
€67.00-€0.60 (-0.89%)
Institut de Développement Industriel SCA’s quoted price sits in the lower half of its reported 52-week range, 9.7% below the high.
€5.75-€0.09 (-1.54%)
ABC arbitrage S.A.’s quoted price sits in the upper half of its reported 52-week range, 3.85% below the high.
€97.00€0.00 (0.0%)
Compagnie Lebon’s quoted price sits in the lower half of its reported 52-week range, 14.16% below the high.
€3.04-€0.03 (-0.98%)
Mexedia Società Per Azioni S.B.’s quoted price sits in the lower half of its reported 52-week range, 89.14% below the high.
